You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《美股業績》輝瑞(PFE.US)季績勝預期 上調復必泰銷售預測
阿思達克 11-02 08:53
美國藥廠輝瑞(Pfizer)(PFE.US)公布第三季業績。季度純利86.06億美元,按年升6%。每股季度攤薄純利1.51美元,經調整後為1.78美元,高於市場預期的1.39美元。季度收入按年跌6%至226.38億美元。 公司上調新冠疫苗復必泰全年銷售預測,由320億美元上調至340億美元。復必泰季內銷售44億美元,高於預期的26億美元。新冠治療藥Paxlovid季度銷售75.1億美元,低於市場預期的76.6億美元。 輝瑞股價昨日(1日)升3.1%,報48.01美元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account